Baecker J, Wartchow K, Sehm T, et al. Treatment with the neurotrophic protein S100B increases synaptogenesis after traumatic brain injury[J]. J Neurotrauma ,2020, 37(8):1097-1107.
Alasady M J, Adipietro K A, Pierce A D, et al. Abstract 315: S100B regulates IL-6 signaling via the p90 ribosomal S6 kinase (RSK) in malignant melanoma[J]. Cancer Res, 2017, 77(13 Supplement):315-315.
Tang S,Xu S,Lu X,et al.Neuroprotective effects of acetyl-l-carnitine on neonatal hypoxia ischemia-induced brain injury in rats[J]. Dev Neurosci, 2017, 38(5):384-396.
Griffin J M, Lee M K, Bangerter L R, et al. Burden and mental health among caregivers of veterans with traumatic brain injury/polytrauma[J]. Am J Orthopsychiatry, 2017, 87(2):139-148.
Mozafari J, Motamed H, Masoumi K, et al. Characteristics of S100B and neuron specific enolase in differentiating acute vertigo cases with central cause; a diagnostic accuracy study[J]. Arch Acad Emerg Med, 2020, 8(1):e3.
Xiong T,Yang X,Qu Y,et al.Erythropoietin induces synaptogenesis and neurite repair after hypoxia ischemia-mediated brain injury in neonatal rats[J]. Neuroreport, 2019, 30(11):783-789.
[39]
Zhao Zh Ch, Benjarat C, Xu H L, et al. Identifying S100B as a biomarker and a therapeutic target for brain injury and multiple diseases[J]. Curr Med Chem ,2016, 23(15):1571-1596.
[40]
Lawrence M. Lewis M D, Derek T, et al. Utility of serum biomarkers in the diagnosis and stratification of mild traumatic brain injury[J]. Acad Emerg Med,2017, 24(6):710-720.